Josie A. Silvaroli

420 total citations
19 papers, 273 citations indexed

About

Josie A. Silvaroli is a scholar working on Molecular Biology, Biochemistry and Cell Biology. According to data from OpenAlex, Josie A. Silvaroli has authored 19 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Biochemistry and 5 papers in Cell Biology. Recurrent topics in Josie A. Silvaroli's work include Retinoids in leukemia and cellular processes (8 papers), Antioxidant Activity and Oxidative Stress (6 papers) and Microtubule and mitosis dynamics (3 papers). Josie A. Silvaroli is often cited by papers focused on Retinoids in leukemia and cellular processes (8 papers), Antioxidant Activity and Oxidative Stress (6 papers) and Microtubule and mitosis dynamics (3 papers). Josie A. Silvaroli collaborates with scholars based in United States, Poland and United Kingdom. Josie A. Silvaroli's co-authors include Marcin Golczak, Made Airanthi K. Widjaja‐Adhi, Surajit Banerjee, Philip D. Kiser, William S. Blaner, Sharyn D. Baker, Ilya Bederman, Alex Sparreboom, Rony R. Sayegh and Zahra Talebi and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and The FASEB Journal.

In The Last Decade

Josie A. Silvaroli

18 papers receiving 270 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Josie A. Silvaroli United States 11 180 67 32 29 27 19 273
Anna M. Dipietrantonio United States 7 330 1.8× 31 0.5× 39 1.2× 19 0.7× 10 0.4× 10 380
Youn‐Kyung Kim United States 13 440 2.4× 240 3.6× 52 1.6× 28 1.0× 21 0.8× 23 611
J.R. Mertz United States 4 315 1.8× 115 1.7× 55 1.7× 24 0.8× 11 0.4× 10 423
H.K. Biesalski Germany 9 190 1.1× 91 1.4× 30 0.9× 44 1.5× 16 0.6× 18 332
Michael Satre United States 11 313 1.7× 57 0.9× 81 2.5× 13 0.4× 21 0.8× 14 398
Elena Shabrova United States 9 217 1.2× 47 0.7× 64 2.0× 9 0.3× 5 0.2× 14 348
Xielan Kuang China 13 227 1.3× 31 0.5× 16 0.5× 99 3.4× 18 0.7× 27 358
Xuerong Sun China 10 151 0.8× 13 0.2× 8 0.3× 36 1.2× 11 0.4× 27 304
James Laird United States 11 193 1.1× 78 1.2× 7 0.2× 108 3.7× 6 0.2× 17 340

Countries citing papers authored by Josie A. Silvaroli

Since Specialization
Citations

This map shows the geographic impact of Josie A. Silvaroli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josie A. Silvaroli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josie A. Silvaroli more than expected).

Fields of papers citing papers by Josie A. Silvaroli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josie A. Silvaroli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josie A. Silvaroli. The network helps show where Josie A. Silvaroli may publish in the future.

Co-authorship network of co-authors of Josie A. Silvaroli

This figure shows the co-authorship network connecting the top 25 collaborators of Josie A. Silvaroli. A scholar is included among the top collaborators of Josie A. Silvaroli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josie A. Silvaroli. Josie A. Silvaroli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Silvaroli, Josie A., et al.. (2024). Role of the CDKL1-SOX11 signaling axis in acute kidney injury. American Journal of Physiology-Renal Physiology. 327(3). F426–F434. 1 indexed citations
2.
Huang, Kevin M., Peter de Bruijn, Mahesh R. Nepal, et al.. (2024). Systematic Evaluation of Tyrosine Kinase Inhibitors as OATP1B1 Substrates Using a Competitive Counterflow Screen. Cancer Research Communications. 4(9). 2489–2497. 2 indexed citations
3.
Silvaroli, Josie A., Carrow I. Wells, Bruce A. Bunnell, et al.. (2024). Discovery and Characterization of a Chemical Probe for Cyclin-Dependent Kinase-Like 2. ACS Medicinal Chemistry Letters. 15(8). 1325–1333.
4.
Ong, Han Wee, William Richardson, Emily R. Lowry, et al.. (2023). Discovery of a Potent and Selective CDKL5/GSK3 Chemical Probe That Is Neuroprotective. ACS Chemical Neuroscience. 14(9). 1672–1685. 7 indexed citations
5.
6.
Eisenmann, Eric D., Zahra Talebi, Yan Jin, et al.. (2022). Interaction of Antifungal Drugs with CYP3A- and OATP1B-Mediated Venetoclax Elimination. Pharmaceutics. 14(4). 694–694. 12 indexed citations
7.
Smith, Christopher A., Emily L. Miedzybrodzka, Josie A. Silvaroli, et al.. (2022). Intestinal Enteroendocrine Cell Signaling: Retinol-binding Protein 2 and Retinoid Actions. Endocrinology. 163(7). 10 indexed citations
8.
Silvaroli, Josie A., et al.. (2021). Molecular basis for the interaction of cellular retinol binding protein 2 (CRBP2) with nonretinoid ligands. Journal of Lipid Research. 62. 100054–100054. 9 indexed citations
9.
Bai, Yuntao, JY Kim, Laura A. Jayne, et al.. (2021). Kidney toxicity of the BRAF-kinase inhibitor vemurafenib is driven by off-target ferrochelatase inhibition. Kidney International. 100(6). 1214–1226. 16 indexed citations
10.
Eisenmann, Eric D., Kevin M. Huang, Josie A. Silvaroli, et al.. (2021). Preclinical Characterization of TP‐0903, a Novel Multikinase Inhibitor, in TP53 Mutant Acute Myeloid Leukemia. The FASEB Journal. 35(S1). 1 indexed citations
11.
Talebi, Zahra, Daelynn R. Buelow, Josie A. Silvaroli, et al.. (2021). Gilteritinib-induced upregulation of S100A9 is mediated through BCL6 in acute myeloid leukemia. Blood Advances. 5(23). 5041–5046. 5 indexed citations
12.
Widjaja‐Adhi, Made Airanthi K., et al.. (2020). Deficiency in Acyl‐CoA:Wax Alcohol Acyltransferase 2 causes evaporative dry eye disease by abolishing biosynthesis of wax esters. The FASEB Journal. 34(10). 13792–13808. 24 indexed citations
13.
Lee, Seung‐Ah, Pierre‐Jacques Brun, Josie A. Silvaroli, et al.. (2020). Retinol-binding protein 2 (RBP2) binds monoacylglycerols and modulates gut endocrine signaling and body weight. Science Advances. 6(11). eaay8937–eaay8937. 21 indexed citations
14.
Silvaroli, Josie A., Made Airanthi K. Widjaja‐Adhi, Surajit Banerjee, et al.. (2019). Abnormal Cannabidiol Modulates Vitamin A Metabolism by Acting as a Competitive Inhibitor of CRBP1. ACS Chemical Biology. 14(3). 434–448. 24 indexed citations
15.
Widjaja‐Adhi, Made Airanthi K., Taylor Hughes, Kevin W. Huynh, et al.. (2017). Allosteric modulation of the substrate specificity of acyl-CoA wax alcohol acyltransferase 2. Journal of Lipid Research. 58(4). 719–730. 13 indexed citations
16.
Widjaja‐Adhi, Made Airanthi K., et al.. (2017). Impact of LCA-Associated E14L LRAT Mutation on Protein Stability and Retinoid Homeostasis. Biochemistry. 56(34). 4489–4499. 9 indexed citations
17.
Silvaroli, Josie A., et al.. (2017). Enzyme That Makes You Cry–Crystal Structure of Lachrymatory Factor Synthase from Allium cepa. ACS Chemical Biology. 12(9). 2296–2304. 17 indexed citations
18.
Silvaroli, Josie A., et al.. (2016). Ligand Binding Induces Conformational Changes in Human Cellular Retinol-binding Protein 1 (CRBP1) Revealed by Atomic Resolution Crystal Structures. Journal of Biological Chemistry. 291(16). 8528–8540. 39 indexed citations
19.
Widjaja‐Adhi, Made Airanthi K., et al.. (2016). Molecular Basis for Vitamin A Uptake and Storage in Vertebrates. Nutrients. 8(11). 676–676. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna M. Dipietrantonio Breakdown of academic impact, for papers by Youn‐Kyung Kim Breakdown of academic impact, for papers by J.R. Mertz Breakdown of academic impact, for papers by H.K. Biesalski Breakdown of academic impact, for papers by Michael Satre Breakdown of academic impact, for papers by Elena Shabrova Breakdown of academic impact, for papers by Xielan Kuang Breakdown of academic impact, for papers by Xuerong Sun Breakdown of academic impact, for papers by James Laird
Rankless by CCL
2026